Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

7-ketocholesterol induces endothelial-mesenchymal transition and promotes fibrosis: implications in neovascular age-related macular degeneration and treatment.

Authors:
Haibo Wang Aniket Ramshekar Eric Kunz M Elizabeth Hartnett

Angiogenesis 2021 Feb 28. Epub 2021 Feb 28.

The John A Moran Eye Center, University of Utah, 65 Mario Capecchi Drive, Salt Lake City, UT, USA.

Oxidized cholesterols and lipids accumulate in Bruch's membrane in age-related macular degeneration (AMD). It remains unknown what causal relationship exists between these substances and AMD pathophysiology. We addressed the hypothesis that a prevalent form, 7-ketocholesterol (7KC), promotes choroidal endothelial cell (CEC) migration and macular neovascularization in AMD. Compared to control, 7KC injection caused 40% larger lectin-stained lesions, but 70% larger lesions measured by optical coherence tomography one week after laser-injury. At two weeks, 7KC-injected eyes had 86% larger alpha smooth muscle actin (αSMA)-labeled lesions and more collagen-labeling than control. There was no difference in cell death. 7KC-treated RPE/choroids had increased αSMA but decreased VE-cadherin. Compared to control-treated CECs, 7KC unexpectedly reduced endothelial VE-cadherin, CD31 and VEGFR2 and increased αSMA, fibroblast activation protein (FAP) and transforming growth factor beta (TGFβ). Inhibition of TGFβ receptor-mediated signaling by SB431542 abrogated 7KC-induced loss of endothelial and increase in mesenchymal proteins in association with decreased transcription factor, SMAD3. Knockdown of SMAD3 partially inhibited 7KC-mediated loss of endothelial proteins and increase in αSMA and FAP. Compared to control, 7KC-treatment of CECs increased Rac1GTP and migration, and both were inhibited by the Rac1 inhibitor; however, CECs treated with 7KC had reduced tube formation. These findings suggest that 7KC, which increases in AMD and with age, induces mesenchymal transition in CECs making them invasive and migratory, and causing fibrosis in macular neovascularization. Further studies to interfere with this process may reduce fibrosis and improve responsiveness to anti-VEGF treatment in non-responsive macular neovascularization in AMD.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10456-021-09770-0DOI Listing
February 2021

Publication Analysis

Top Keywords

macular neovascularization
12
macular degeneration
8
neovascularization amd
8
compared control
8
loss endothelial
8
age-related macular
8
increased αsma
8
amd
5
macular
5
7kc
5
growth factor
4
transforming growth
4
factor beta
4
beta tgfβ
4
tgfβ inhibition
4
fap transforming
4
protein fap
4
vegfr2 increased
4
cd31 vegfr2
4
αsma fibroblast
4

Keyword Occurance

Similar Publications

Current Management of Age-Related Macular Degeneration.

Authors:
Cindy Ung Ines Lains Joan W Miller Ivana K Kim

Adv Exp Med Biol 2021 ;1256:295-314

Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.

Age-related macular degeneration (AMD) remains a leading cause of blindness worldwide. The assessment and management of patients with this condition has evolved in the last decades. In this chapter, current standards for diagnosis, follow-up, and treatment of patients with AMD are reviewed and summarized. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Immunological Aspects of Age-Related Macular Degeneration.

Authors:
Michael J Allingham Anna Loksztejn Scott W Cousins Priyatham S Mettu

Adv Exp Med Biol 2021 ;1256:143-189

Department of Ophthalmology, Duke Center for Macular Diseases, Duke Eye Center, Duke University School of Medicine, Durham, NC, USA.

Increasing evidence over the past two decades points to a pivotal role for immune mechanisms in age-related macular degeneration (AMD) pathobiology. In this chapter, we will explore immunological aspects of AMD, with a specific focus on how immune mechanisms modulate clinical phenotypes of disease and severity and how components of the immune system may serve as triggers for disease progression in both dry and neovascular AMD. We will briefly review the biology of the immune system, defining the role of immune mechanisms in chronic degenerative disease and differentiating from immune responses to acute injury or infection. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Innate Immunity in Age-Related Macular Degeneration.

Authors:
Yikui Zhang Wai T Wong

Adv Exp Med Biol 2021 ;1256:121-141

Section on Neuron-Glia Interactions in Retinal Disease, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

Multiple lines of investigation have demonstrated that inflammation plays significant roles in etiology of age-related macular degeneration (AMD). Although interventional trials in AMD therapy targeting inflammatory pathways have been conducted, they have not yet been successful and a detailed understanding as to why some have failed is still elusive. One limitation is the relative dearth of information on how immune cells interact with retinal cells to generate AMD phenotypes at each disease stage. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Bruch's Membrane and the Choroid in Age-Related Macular Degeneration.

Authors:
Malia Edwards Gerard A Lutty

Adv Exp Med Biol 2021 ;1256:89-119

Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore, MD, USA.

A healthy choroidal vasculature is necessary to support the retinal pigment epithelium (RPE) and photoreceptors, because there is a mutualistic symbiotic relationship between the components of the photoreceptor/retinal pigment epithelium (RPE)/Bruch's membrane (BrMb)/choriocapillaris (CC) complex. This relationship is compromised in age-related macular degeneration (AMD) by the dysfunction or death of the choroidal vasculature. This chapter will provide a basic description of the human Bruch's membrane and choroidal anatomy and physiology and how they change in AMD. Read More

View Article and Full-Text PDF
January 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap